ChondroGenesis, Inc. was founded for the purpose of bringing a new, non-invasive process to market for the treatment of ear cartilage shape disorders. ChondroGenesis has developed a non-surgical process to produce new soft cartilage, which is allowed to heal in the desired shape using a comfortably-designed proprietary system. This uniquely new process, called Cartilaze™, is used to correct ear deformations, which are currently being corrected via complex surgical methods. ChondroGenesis will market Cartilaze to medical professionals world wide.
The Cartilaze process is non-invasive, requiring no anesthesia and eliminating all the downsides associated with current techniques. It is completely painless, with no side effects or downtime and can be performed by a nurse or Medical Assistant, freeing the time of the surgeon, which would allow additional revenue generation. The Cartilaze process is effective in treating 80% of all ear deformations. ChondroGenesis has completed and published a number of clinical studies demonstrating the efficacy of Cartilaze. Publications are available upon request.
The founders of ChondroGenesis include:
- Jack Savage, co-founder, CEO, and Chairman with a successful 28-year track record of bringing new laser and other medical device technologies to successful commercialization having over 20 years medical laser product and clinical development experience. Mr. Savage is an expert at creating revenue, profit, and market-share growth for companies serving medical marketplace. As CEO and President, he has been a catalyst for dynamic growth at five different companies –starts-ups, early-stage technology pioneers, and others well established but needing the visionary leadership to reach the next level of success.
If you are interested in learning more about Cartilaze, please contact us at: (801) 942-4590 or email us.